{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:19Z","timestamp":1791918919780,"version":"4.3.4"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.expneurol.2024.115071","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:28:44Z","timestamp":1732328924000},"page":"115071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis"],"prefix":"10.1016","volume":"384","author":[{"given":"Mahan","family":"Farzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Saberi-Rounkian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Asadi-Rizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahour","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Azadegan-Dehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.115071_bb0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fneur.2019.00280","article-title":"Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?","volume":"10","author":"Abdelhak","year":"2019","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2967\/jnumed.114.149955","article-title":"In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis","volume":"56","author":"Airas","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2024.115071_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fneur.2018.00181","article-title":"Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography","volume":"9","author":"Airas","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0312145","article-title":"TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors","volume":"93","author":"Arts","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"43","key":"10.1016\/j.expneurol.2024.115071_bb0025","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2024.115071_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104323","article-title":"Radiological markers capable of differentiating multiple sclerosis from neuromyelitis optica spectrum disorder; a systematic review and Meta-analysis","volume":"71","author":"Bagherieh","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0045","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis","volume":"44","author":"Bagherieh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"43","key":"10.1016\/j.expneurol.2024.115071_bb0050","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115071_bb0055","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","article-title":"A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response","volume":"170","author":"Bleharski","year":"2003","journal-title":"The Journal of Immunology."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.09.017","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0065","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0070","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0075","first-page":"9","article-title":"Increase of TREM2 during aging of an Alzheimer\u2019s disease mouse model is paralleled by microglial activation and amyloidosis. Frontiers in aging","author":"Brendel","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","article-title":"TREM2 regulates microglial cell activation in response to demyelination in vivo","volume":"129","author":"Cantoni","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"16","key":"10.1016\/j.expneurol.2024.115071_bb0085","first-page":"7935","article-title":"TREM2 impacts brain microglia, oligodendrocytes and endothelial co-expression modules revealing genes and pathways important in Alzheimer\u2019s disease","volume":"7","author":"Carbajosa","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ene.13583","article-title":"Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer\u2019s disease","volume":"25","author":"Casati","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.expneurol.2024.115071_bb0100","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nn.4126","article-title":"CD33 modulates TREM2: convergence of Alzheimer loci","volume":"18","author":"Chan","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","article-title":"The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"318","author":"Chu","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"issue":"Supplement_2","key":"10.1016\/j.expneurol.2024.115071_bb0125","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1086\/374754","article-title":"TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses","volume":"187","author":"Colonna","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0140","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0145","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.1107","article-title":"Immune function of astrocytes","volume":"36","author":"Dong","year":"2001","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tins.2022.03.002","article-title":"Oxidized phospholipids as novel mediators of neurodegeneration","volume":"45","author":"Dong","year":"2022","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","article-title":"Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia","volume":"24","author":"Dong","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-022-02443-9","article-title":"CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study","volume":"19","author":"Dong","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2024.115071_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","article-title":"Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies","volume":"218","author":"Elfawy","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017742118","article-title":"Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer\u2019s disease","volume":"118","author":"Ellwanger","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.expneurol.2024.115071_bb0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209177120","article-title":"Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer\u2019s disease","volume":"120","author":"Fairley","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fnins.2019.00769","article-title":"Therapeutic effect of modulating TREM-1 via anti-inflammation and autophagy in Parkinson\u2019s disease","volume":"13","author":"Feng","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: innocent bystander or active player in neurological diseases?","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.115071_bb0195","article-title":"Soluble TREM2: innocent bystander or active player in neurological diseases?","volume":"105630","author":"Filipello","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","article-title":"TREM and TREM-like receptors in inflammation and disease","volume":"21","author":"Ford","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0205","first-page":"4230","article-title":"Tumor-infiltrating myeloid cells co-express TREM1 and TREM2 and elevated TREM-1 associates with disease progression in renal cell carcinoma","author":"Ford","year":"2022","journal-title":"Frontiers in Oncology."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030686","article-title":"Microglial pruning: relevance for synaptic dysfunction in multiple sclerosis and related experimental models","volume":"10","author":"Geloso","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00011-018-1185-0","article-title":"A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad","year":"2019","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imm.12177","article-title":"Can we switch microglia\u2019s phenotype to foster neuroprotection? Focus on multiple sclerosis","volume":"141","author":"Giunti","year":"2014","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0230","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210227","article-title":"TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination","volume":"218","author":"Gouna","year":"2021","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","article-title":"Immune cell regulation of glia during CNS injury and disease","volume":"21","author":"Greenhalgh","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.expneurol.2024.115071_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.06.005","article-title":"A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family","volume":"34","author":"Guerreiro","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2024.115071_bb0250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in multiple sclerosis: friend or foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0255","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12","volume":"177","author":"Hamerman","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0260","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/00207454.2016.1264072","article-title":"Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases","volume":"127","author":"Han","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","article-title":"The role of glial cells in multiple sclerosis disease progression","volume":"18","author":"Healy","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-022-00588-y","article-title":"TREM2 dependent and independent functions of microglia in Alzheimer\u2019s disease","volume":"17","author":"Hou","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2024.115071_bb0275","doi-asserted-by":"crossref","first-page":"1280257","DOI":"10.3389\/fcell.2023.1280257","article-title":"The role of TREM2 in Alzheimer\u2019s disease: from the perspective of tau","volume":"11","author":"Huang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0280","doi-asserted-by":"crossref","DOI":"10.1177\/20552173211019772","article-title":"Correlations between macrophage\/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis","volume":"7","author":"Ioannides","year":"2021","journal-title":"Multiple Sclerosis Journal\u2013Experimental, Translational and Clinical"},{"issue":"18 Supplement","key":"10.1016\/j.expneurol.2024.115071_bb0285","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1212\/WNL.98.18_supplement.2423","article-title":"INVOKE-2 - a phase 2 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of AL002 in participants with early Alzheimer\u2019s disease (P17-3.005)","volume":"98","author":"Jackson","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","article-title":"TREM2 in neurodegenerative diseases","volume":"12","author":"Jay","year":"2017","journal-title":"Molecular Neurodegeneration."},{"issue":"12","key":"10.1016\/j.expneurol.2024.115071_bb0295","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0300","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13365-020-00844-1","article-title":"Differential regulation of TREM2 and CSF1R in CNS macrophages in an SIV\/macaque model of HIV CNS disease","volume":"26","author":"Knight","year":"2020","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ecco-jcc\/jjx129","article-title":"TREM-1 inhibition restores impaired autophagy activity and reduces colitis in mice","volume":"12","author":"K\u00f6kten","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.expneurol.2024.115071_bb0310","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fncel.2018.00206","article-title":"Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases","volume":"12","author":"Konishi","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"30","key":"10.1016\/j.expneurol.2024.115071_bb0320","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1073\/pnas.1901283116","article-title":"pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis","volume":"116","author":"Kremer","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0325","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2018.00178","article-title":"mCSF-induced microglial activation prevents myelin loss and promotes its repair in a mouse model of multiple sclerosis","volume":"12","author":"Laflamme","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0330","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2018.00178","article-title":"mCSF-induced microglial activation prevents myelin loss and promotes its repair in a mouse model of multiple sclerosis","volume":"12","author":"Laflamme","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0335","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and beyond: innate immune cells as regulators of brain development and behavioral function","volume":"9","author":"Lenz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115218","article-title":"TREM2: potential therapeutic targeting of microglia for Alzheimer\u2019s disease","volume":"165","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"19","key":"10.1016\/j.expneurol.2024.115071_bb0345","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","article-title":"Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions","volume":"29","author":"Liu","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115071_bb0350","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/NDT.S140634","article-title":"The role of microglia in multiple sclerosis","volume":"13","author":"Luo","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0355","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/ijms24031861","article-title":"Role of microglial cells in the pathophysiology of MS: synergistic or antagonistic?","volume":"24","author":"Mado","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0360","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood.V96.6.2181","article-title":"Signaling via LAT (linker for T-cell activation) and Syk\/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation","volume":"96","author":"Martelli","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.expneurol.2024.115071_bb0365","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nrl.2021.10.005","article-title":"Gadolinium-enhanced brain lesions in multiple sclerosis relapse","volume":"37","author":"Mart\u00edn-Aguilar","year":"2022","journal-title":"Neurologia (Engl Ed)."},{"key":"10.1016\/j.expneurol.2024.115071_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.672455","article-title":"Cross-talk of the CNS with immune cells and functions in health and disease","volume":"12","author":"Matejuk","year":"2021","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2024.115071_bb0375","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","article-title":"Immunologic privilege in the central nervous system and the blood-brain barrier","volume":"33","author":"Muldoon","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2009.04.024","article-title":"Protective effects of microglia in multiple sclerosis","volume":"225","author":"Napoli","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0390","doi-asserted-by":"crossref","DOI":"10.1177\/1536012118792317","article-title":"Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO","volume":"17","author":"Narayanaswami","year":"2018","journal-title":"Mol. Imaging"},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0395","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/cells8101124","article-title":"TREM receptors connecting bowel inflammation to neurodegenerative disorders","volume":"8","author":"Natale","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0400","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/glia.24052","article-title":"Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain","volume":"69","author":"Nutma","year":"2021","journal-title":"Glia"},{"issue":"12","key":"10.1016\/j.expneurol.2024.115071_bb0405","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1177\/1352458515624558","article-title":"Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone","volume":"22","author":"\u00d6hrfelt","year":"2016","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0410","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.25691","article-title":"CHIT1 at diagnosis reflects long-term multiple sclerosis disease activity","volume":"87","author":"Oldoni","year":"2020","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0415","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028993","article-title":"Microglial phenotypes and functions in multiple sclerosis","volume":"8","author":"O\u2019Loughlin","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0420","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028993","article-title":"Microglial phenotypes and functions in multiple sclerosis","volume":"8","author":"O\u2019Loughlin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.expneurol.2024.115071_bb0425","first-page":"56","article-title":"Divergent neuroinflammatory regulation of microglial TREM expression and involvement of NF-\u03baB","volume":"11","author":"Owens","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0430","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-015-0040-9","article-title":"TREM2 in CNS homeostasis and neurodegenerative disease","volume":"10","author":"Painter","year":"2015","journal-title":"Molecular Neurodegeneration."},{"issue":"S9","key":"10.1016\/j.expneurol.2024.115071_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/alz.054615","article-title":"INVOKE-2: a phase 2 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of AL002 in participants with early Alzheimer\u2019s disease","volume":"17","author":"Paul","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2024.115071_bb0440","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3(122):ra38","author":"Peng","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2024.115071_bb0445","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroscience.2014.04.036","article-title":"The role of the immune system in central nervous system plasticity after acute injury","volume":"283","author":"Peruzzotti-Jametti","year":"2014","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0450","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"Pt 11","key":"10.1016\/j.expneurol.2024.115071_bb0455","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.expneurol.2024.115071_bb0460","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.expneurol.2024.115071_bb0465","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.3390\/ijms21175960","article-title":"Microglial phagocytosis\u2014rational but challenging therapeutic target in multiple sclerosis","volume":"21","author":"Pinto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0470","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1172\/JCI77983","article-title":"TREM2 sustains microglial expansion during aging and response to demyelination","volume":"125","author":"Poliani","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2024.115071_bb0475","doi-asserted-by":"crossref","first-page":"1103416","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2016.05.021","article-title":"Multiple sclerosis: the resolving lesion revealed","volume":"304","author":"Raine","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0485","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109108","article-title":"Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency","volume":"41","author":"Reifschneider","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2024.115071_bb0490","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.msard.2019.07.007","article-title":"TREM2 R47H (rs75932628) variant is unlikely to contribute to multiple sclerosis susceptibility and severity in a large Greek MS cohort","volume":"35","author":"Rikos","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.expneurol.2024.115071_bb0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115071_bb0500","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"issue":"39","key":"10.1016\/j.expneurol.2024.115071_bb0505","doi-asserted-by":"crossref","first-page":"24464","DOI":"10.1073\/pnas.2007814117","article-title":"Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection","volume":"117","author":"Sariol","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0510","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000571","article-title":"African Americans have differences in CSF soluble TREM2 and associated genetic variants","volume":"7","author":"Schindler","year":"2021","journal-title":"Neurol Genet."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.it.2021.01.005","article-title":"Diversity and function of glial cell types in multiple sclerosis","volume":"42","author":"Schirmer","year":"2021","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0520","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2024.115071_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113977","article-title":"The role of triggering receptor expressed on myeloid cells 2 in Parkinson\u2019s disease and other neurodegenerative disorders","volume":"433","author":"Schwarz","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0530","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1460-9568.2004.03729.x","article-title":"Distribution and signaling of TREM2\/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia","volume":"20","author":"Sessa","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02582-z","article-title":"The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study","volume":"19","author":"Shi","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0540","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1038\/s41598-019-43535-6","article-title":"Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells","volume":"9","author":"Shirotani","year":"2019","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.expneurol.2024.115071_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168404","article-title":"Astroglial and microglial purinergic P2X7 receptor as a major contributor to Neuroinflammation during the course of multiple sclerosis","volume":"22","author":"Sidoryk-W\u0119grzynowicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.expneurol.2024.115071_bb0550","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.3390\/ijms22168404","article-title":"Astroglial and microglial purinergic P2X7 receptor as a major contributor to neuroinflammation during the course of multiple sclerosis","volume":"22","author":"Sidoryk-W\u0119grzynowicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0555","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","article-title":"Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation","volume":"13","author":"Song","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0560","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-4159.2009.06130.x","article-title":"The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor","volume":"110","author":"Stefano","year":"2009","journal-title":"J. Neurochem."},{"issue":"20","key":"10.1016\/j.expneurol.2024.115071_bb0565","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104247","article-title":"\u03b3-Secretase cleavage of the Alzheimer risk factor TREM2 is determined by its intrinsic structural dynamics","volume":"39","author":"Steiner","year":"2020","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"issue":"10","key":"10.1016\/j.expneurol.2024.115071_bb0575","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","article-title":"Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease","volume":"19","author":"Tan","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0580","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.expneurol.2024.115071_bb0585","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/stem.3374","article-title":"Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis","volume":"39","author":"Tsouki","year":"2021","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nri2014","article-title":"Activating and inhibitory functions of DAP12","volume":"7","author":"Turnbull","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0595","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.expneurol.2024.115071_bb0600","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.3748\/wjg.v12.i21.3416","article-title":"Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease","volume":"12","author":"Tzivras","year":"2006","journal-title":"World J Gastroenterol: WJG"},{"issue":"11","key":"10.1016\/j.expneurol.2024.115071_bb0605","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2024.115071_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105681","article-title":"Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): an updated systematic review and meta-analysis","volume":"87","author":"Vaheb","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0615","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-024-46068-3","article-title":"Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation","volume":"15","author":"van den Bosch","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08976-7","article-title":"Transcriptional profiling of human microglia reveals grey\u2013white matter heterogeneity and multiple sclerosis-associated changes","volume":"10","author":"van der Poel","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0625","first-page":"416","article-title":"A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models","volume":"26","author":"van Lengerich","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0630","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-021-02293-4","article-title":"Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration","volume":"141","author":"van Olst","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115071_bb0635","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1352458517739139","article-title":"Much, if not all, of the cortical damage in MS can be attributed to the microglial cell\u2013yes","volume":"24","author":"van Wageningen","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0640","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","article-title":"Microglia in central nervous system inflammation and multiple sclerosis pathology","volume":"25","author":"Voet","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0645","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","article-title":"Microglia in central nervous system inflammation and multiple sclerosis pathology","volume":"25","author":"Voet","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0650","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2011.09.008","article-title":"Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?","volume":"45","author":"Voss","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0655","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2024.115071_bb0660","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2019.00286","article-title":"Targeting microglia and macrophages: a potential treatment strategy for multiple sclerosis","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.expneurol.2024.115071_bb0665","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0670","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/glia.24335","article-title":"TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection","volume":"71","author":"Wang","year":"2023","journal-title":"Glia"},{"issue":"S9","key":"10.1016\/j.expneurol.2024.115071_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/alz.054669","article-title":"A phase 1 study of AL002 in healthy volunteers","volume":"17","author":"Ward","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"18 Supplement","key":"10.1016\/j.expneurol.2024.115071_bb0680","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1212\/WNL.98.18_supplement.3133","article-title":"A phase 1 study of AL002 in healthy volunteers (P5-3.004)","volume":"98","author":"Ward","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0685","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/14737175.2019.1614443","article-title":"Glial cells as therapeutic targets in progressive multiple sclerosis","volume":"19","author":"Wilbanks","year":"2019","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0690","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41593-024-01610-w","article-title":"TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models","volume":"27","author":"Wilson","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0695","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0271678X221137762","article-title":"The roles of microglia and astrocytes in myelin phagocytosis in the central nervous system","volume":"43","author":"Xu","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0700","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","article-title":"TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease","volume":"17","author":"Yang","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115071_bb0705","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-Beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115071_bb0710","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, microglia, and neurodegenerative diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.expneurol.2024.115071_bb0715","doi-asserted-by":"crossref","first-page":"5150678","DOI":"10.1155\/2017\/5150678","article-title":"The role of microglia and macrophages in CNS homeostasis, autoimmunity, and Cancer","volume":"2017","author":"Yin","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115071_bb0720","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-023-02772-3","article-title":"TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder","volume":"20","author":"You","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2024.115071_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.872134","article-title":"The emerging role of central and peripheral immune Systems in Neurodegenerative Diseases","volume":"14","author":"Zang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2024.115071_bb0730","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ane.12845","article-title":"Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis","volume":"136","author":"Zetterberg","year":"2017","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115071_bb0735","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","article-title":"TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease","volume":"499","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.expneurol.2024.115071_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2024.115071_bb0745","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","article-title":"Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia","volume":"353","author":"Zheng","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115071_bb0750","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-181038","article-title":"TREM2 variants and neurodegenerative diseases: a systematic review and meta-analysis","volume":"68","author":"Zhou","year":"2019","journal-title":"J. Alzheimers Dis."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:35:26Z","timestamp":1764840926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624003972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":150,"alternative-id":["S0014488624003972"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115071","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115071"}}